"I love STAT - Reporting from the frontiers of health and medicine"

2022-05-08 15:38:01

Skip to Main ContentRead all of our coverage of the coronavirus and Covid-19.CommunityTry STAT+ TODAYContributeLog InTry STAT+ TODAYMy AccountMy AccountBillingLog OutTry STAT+My AccountTOPICSCoronavirusHealthPharmaBiotechPolitics & PolicyHealth TechIn the LabBusinessArtificial IntelligenceVaccinesHealth DisparitiesPrescription PoliticsOPINIONFirst OpinionThe Pharmalot ViewAdam's TakeMatt's TakeOff the ChartsTEAMBiotech & PharmaAllison DeAngelisAdam FeuersteinDamian GardeMatthew HerperMeghana KeshavanKate SheridanEd SilvermanJonathan WosenHealth TechMario AguilarKatie PalmerMohana RavindranathCasey RossBusiness & PolicyRachel CohrsLev FacherNicholas FlorkoBob HermanHealth & ScienceEric BoodmanHelen BranswellAngus ChenElizabeth CooneyIsabella CuetoTheresa GaffneyOlivia GoldhillAndrew JosephMegan MolteniUsha Lee McFarlingJennifer Adaeze OkwerekwuNicholas St. FleurTeamView AllEVENTSUpcoming Industry EventsSTAT EventsSTAT Summits2022 STAT Health Tech SummitPODCASTSColor CodeFirst Opinion PodcastThe Readout LOUDNEWSLETTERSRESOURCESSTAT Trials PulseReportsE-booksVIDEOSTAT+Exclusive analysis of biotech, pharma, and the life sciencesLearn MoreThe LatestMy AccountTopicsBiotechPharmaPolicyHealth TechBusinessColumnsAdam's TakeMatt's TakeThe Pharmalot ViewToolsCRISPR TrackrBreakthrough Device TrackerDrug Pricing Policy Cheat SheetEventsSTAT+ ConversationsAll STAT EventsTeamBiotech and PharmaHealth TechPolitics and PolicyHealth and ScienceAccountMy AccountBillingSubscribeLog InHelpMoreCommunityContributeGroup SubscriptionsFollow UsTrending:CoronavirusFirst OpinionHealthBiotechSTAT — Reporting from the frontiers of health and medicineExclusiveWhite House documents detail a looming squeeze on Covid-19 boostersHealthSurgeons navigating their pregnancies see a bleak picture getting a bit brighterBusinessOmicron squeezed hospitals more than health insurers in the first quarterFirst OpinionHealth care workers need rescuing. It’s time for a Dunkirk momentExclusivePrisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugsHealthFDA limits use of Johnson & Johnson’s Covid-19 vaccine, citing clotting riskHealth TechCerebral, under intense scrutiny, is ‘actively adjusting’ strategy on ADHD adsMore StoriesFirst OpinionBuilding scientific talent in the Global South can help prevent future public health crisesBy Muhammad Ali Pate and Michelle A. WilliamsBiotechCovid shots made Moderna biotech’s biggest star, but what now?By Ryan Cross — The Boston GlobeHealthCDC investigating 109 unusual hepatitis cases in kids in outbreakBy Helen BranswellExclusiveWhite House documents detail a looming squeeze on Covid-19 boostersHealthSurgeons navigating their pregnancies see a bleak picture getting a bit brighterBusinessOmicron squeezed hospitals more than health insurers in the first quarterFirst OpinionHealth care workers need rescuing. It’s time for a Dunkirk momentExclusivePrisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugsHealthFDA limits use of Johnson & Johnson’s Covid-19 vaccine, citing clotting riskHealth TechCerebral, under intense scrutiny, is ‘actively adjusting’ strategy on ADHD adsMore StoriesExclusive analysis of biotech, pharma, and the life sciencesLearn moreDaily, market-moving coverage of biotech and pharmaInside intelligence on the NIH, the FDA, and CongressProfiles of the power players shaping the industryAnalysis of the latest scientific developmentsStart your free trial!Novartis suspends production of two cancer therapies over potential quality issuesIllumina, maker of a key tool for drug discovery, to try making new drugs itselfUp and down the ladder: The latest comings and goingsadvertisementHeavyweights‘Where the bats hung out’: How a basement hideaway at UC Berkeley nurtured a generation of blind innovatorsBy Isabella CuetoA STAT InvestigationAI gone astray: How subtle shifts in patient data send popular algorithms reeling, undermining patient safetyBy Casey RossDon't MissIntroducing the STATUS List, the definitive accounting of leaders in the life sciencesBy STATHeavyweights‘I’m going to prove you wrong’: How a D.C. power couple used an ALS diagnosis to create a political juggernautBy Lev FacherSpecial ReportBiogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brinkBy Adam Feuerstein and Damian GardeSpecial Report20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed?By Usha Lee McFarlingSpecial ReportHow medicine erased Black women from a ‘white man’s disease’By Eric BoodmanA STAT InvestigationThe whitest specialty: As medicine strives to close its diversity gaps, one field remains a stubborn outlierBy Usha Lee McFarlingHealthCDC investigating 109 unusual hepatitis cases in kids in outbreakExclusiveWhite House documents detail a looming squeeze on Covid-19 boostersIn the LabA lucky few seem ‘resistant’ to Covid-19. Scientists want to know whyHealthMore uniformly infectious, more treatable, more genetically predictable: How coronavirus is getting closer to fluBusinessThe doctor who is trying to bring back surprise billingFirst Opinion PodcastListen: How should doctors treat chronic pain in the wake of the opioid crisis?Health TechHe had an M.D. and a Ph.D. but didn’t match into a residency. It was the push he needed to jump into health techHealthPfizer to seek Covid booster for healthy 5- to 11-year-oldsIn the Lab‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims — and finding some truthAll Popular StoriesColor CodeListen: ‘Birthing while Black’ is an American crisis. Communities demand justiceBy Nicholas St. FleurFirst Opinion PodcastListen: How should doctors treat chronic pain in the wake of the opioid crisis?By Patrick SkerrettSpecial ReportDISTANCED: Pandemic stories of Black life in the rural SouthBy Bethany MollenkofThe Readout LOUDListen: Succession at Biogen, surprises at Vertex, & a potential superspreader dinnerBy Damian Garde, Meg Tirrell and Adam FeuersteinReporter SpotlightMario covers how technology is transforming health care. Mario's ProfileTara Bannow covers hospitals, providers, and insurers.Tara's ProfileCasey covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. He is the co-author of the newsletter STAT Health Tech.Casey's Profile View AllMario's LatestMore from MarioHealth TechNew funding for Curebase and Sidekick Health, Talkspace earnings, and Cerebral setbacksBy Mohana Ravindranath and Mario AguilarHealth TechTeladoc takes a hit with $6.6 billion impairment charge on LivongoBy Mohana Ravindranath and Mario AguilarMore from MarioTara's LatestMore from TaraBusinessOmicron squeezed hospitals more than health insurers in the first quarterBy Tara Bannow and Bob HermanHospitalsHospital giant Tenet sues OSHA for attempting to inspect hospital under Covid-19 worker safety ruleBy Tara BannowMore from TaraCasey's LatestMore from CaseyHealth TechTruepill halts Adderall prescriptions, heart algorithm taps Apple Watch data, and home health sees a goldrushBy Casey Ross and Katie PalmerHealth TechAn algorithm that analyzes Apple Watch data shows early promise in detecting heart problemsBy Casey RossMore from CaseySign up for our morning rounds newsletterReporting from the frontiers of health and medicineTrending:CoronavirusFirst OpinionHealthBiotechPharmaPharmalotBack to topCompanyAbout STATAwardsContact UsCareers & InternshipsContributeDiversity & InclusionLicensing StoriesOur TeamAccountAbout STAT+FAQsLog InSubscribeApp & Other ProductsSTAT AppNewslettersPodcastsSTAT MadnessSTAT ReportsSTAT Trials PulseSTAT WunderkindsGroup SubscriptionsContact UsRequest A QuoteAdvertisingAdvertise With UsEventsUpcoming Industry EventsSTAT EventsSTAT SummitsSponsor An EventPrivacyComment PolicyTermsDo Not Sell my Data©2022 STAT